The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 05, 2015

Filed:

Mar. 26, 2010
Applicants:

Kazuhiro Morishita, Miyazaki, JP;

Shingo Nakahata, Miyazaki, JP;

Makoto Hamasaki, Miyazaki, JP;

Inventors:

Kazuhiro Morishita, Miyazaki, JP;

Shingo Nakahata, Miyazaki, JP;

Makoto Hamasaki, Miyazaki, JP;

Assignee:

Miyazaki Prefecture, Miyazaki, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/46 (2006.01); C12N 15/00 (2006.01); G01N 33/53 (2006.01); C12Q 1/48 (2006.01); A61K 31/223 (2006.01); A61K 31/7088 (2006.01); C07K 16/40 (2006.01); C07K 16/44 (2006.01); C12N 9/12 (2006.01); C12N 9/18 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/485 (2013.01); A61K 31/223 (2013.01); A61K 31/7088 (2013.01); C07K 16/40 (2013.01); C07K 16/44 (2013.01); C07K 2317/34 (2013.01); C12N 9/12 (2013.01); C12N 9/18 (2013.01); G01N 2500/00 (2013.01); A61K 48/005 (2013.01);
Abstract

Provided is a preventive, progression inhibitor or remedy for a disease one of the causes of which is the activation of the P13K/AKT signaling pathway or vice versa. A phosphorylation-inhibiting and/or dephosphorylating agent, which has an effect of inhibiting the phosphorylation at least at one of the phosphorylation sites of PTEN protein selected from the group consisting of T382, T383 and S380 and/or an effect of dephosphorylating the same, is prepared. Alternatively, a phosphorylation-inhibiting or dephosphorylating agent for PTEN is screened by a method comprising a step for confirming an ability of a test substance to inhibit the phosphorylation at least at one of the phosphorylation sites of PTEN protein selected from the group consisting of T382, T383 and S380 or a dephosphorylation ability thereof. Then, a substance having an effect opposite to the inhibition of PTEN phosphorylation or dephosphorylation thereof, e.g., an antibody against the phosphorylation-inhibiting or dephosphorylating agent for PTEN obtained above, is also obtained.


Find Patent Forward Citations

Loading…